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RESEARCH ARTICLE
Role of neuromedin B and its 
receptor in the innate immune responses 
against influenza A virus infection in vitro 
and in vivo
Guihong Yang*† , Huipeng Huang†, Mengyao Tang†, Zifeng Cai, Cuiqin Huang, Baomin Qi and Ji‑Long Chen*
Abstract 
The peptide neuromedin B (NMB) and its receptor (NMBR) represent a system (NMB/NMBR) of neuromodulation. 
Here, it was demonstrated that the expression of NMBR in cells or murine lung tissues was clearly upregulated in 
response to H1N1/PR8 influenza A virus infection. Furthermore, the in vitro and in vivo activities of NMB/NMBR during 
PR8 infection were investigated. It was observed that A549 cells lacking endogenous NMBR were more susceptible to 
virus infection than control cells, as evidenced by the increased virus production in the cells. Interestingly, a significant 
decrease in IFN‑α and increased IL‑6 expression were observed in these cells. The role of this system in innate immu‑
nity against PR8 infection was probed by treating mice with NMB. The NMB‑treated mice were less susceptible to virus 
challenge, as evidenced by increased survival, increased body weight, and decreased viral NP expression compared 
with the control animals. Additionally, the results showed that exogenous NMB not only enhanced IFN‑α expression 
but also appeared to inhibit the expression of NP and IL‑6 in PR8‑infected cells and animals. As expected, opposing 
effects were observed in the NMBR antagonist‑treated cells and mice, which further confirmed the effects of NMB. 
Together, these data suggest that NMB/NMBR may be an important component of the host defence against influenza 
A virus infection. Thus, these proteins may serve as promising candidates for the development of novel antiviral drugs.
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Influenza A viruses (IAVs) invade the respiratory tract, 
causing direct damage via viral replication and indirect 
damage via the host’s excessive defensive, production of 
inflammatory cytokines, called the cytokine storm [1]. 
Cytokine dysregulation contributes to the pathogenesis 
of H1N1, H5N1 and H7N9 viruses [2, 3] by inducing an 
imbalance in the host regulatory network, which results 
in severe complications and ultimately high mortality 
rates [4, 5]. The most important methods for preventing 
and controlling IAV are antiviral treatments and annual 
vaccination. However, IAV antigens can mutate rapidly 
through the processes of antigenic drift and antigenic 
shift. As a result, drug-resistant viruses are continu-
ally emerging [6]. Over time, drug-resistant subtypes of 
IAV have been observed to escape the actions of antivi-
ral drugs [7, 8]. Several drugs, such as amantadine and 
rimantadine, have been withdrawn from the market as a 
result of their reduced efficacy [9–12]. Currently, availa-
ble antiviral drugs have several disadvantages: many neg-
ative side effects [13, 14], increased drug resistance, and 
single-target modes of action [7, 9, 10, 13, 15]. Thus, anti-
influenza drug development has increasingly focussed on 
host immunoregulation [16]. In response to viral infec-
tion, rapid induction of cytokines, including type I inter-
feron (IFN-α/β), is central to the establishment of innate 
antiviral immunity [17, 18]. It has been demonstrated 
that neuroendocrine molecules are capable of regulat-
ing cytokine responses through auto- or self-secretions 
[19]. Therefore, neuroendocrine molecules may serve 
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as promising candidates for the development of novel 
and potent antiviral drugs. Such members include neu-
romedin B (NMB), neuromedin U, and neuropeptide S. 
In particular, NMB has been shown to directly regulate 
IL-6 expression in tissues as well as its secretion into the 
serum of animals [20, 21]. Therefore, the potential antivi-
ral efficacy of NMB warrants further investigation.
To date, few reports have evaluated the role of NMB 
and NMBR in the process of IAV infection in animals. 
To this end, the potential anti-influenza activity of NMB 
and its receptor NMBR were examined here. Since it is 
very difficult to obtain natural NMB, the NMB used here 
was chemically synthesized. Additionally, a synthetic 
NMBR antagonist (NMBRA) was employed. First, NMB 
and NMBR expression was measured in PR8-infected 
cells and animals. Next, cells with a stable knockdown 
of NMBR were generated to assess its role in the host 
responses to IAV infection. NMBR-knockdown cells were 
more susceptible to PR8 infection than control cells. In 
addition, the effects of NMB and NMBRA treatment on 
PR8 infection both in vitro and in vivo were determined, 
which provided initial evidence that NMB and NMBR 
exert anti-H1N1 IAV effects.
Materials and methods
Animals and ethics statement
Specific pathogen-free (SPF) C57BL/6J mice at an 
age range of 5–6  weeks used in the present study were 
obtained from the WUSHI animal centre (Shanghai, 
China). The animals were housed in sterile cages under 
laminar airflow hoods in a SPF room with a 12  h:12  h 
light–dark schedule. Animals were provided autoclaved 
feed and water ad libitum. This study was carried out in 
strict accordance with the Regulations for the Admin-
istration of Affairs Concerning Experimental Animals 
approved by the State Council of China. The study pro-
tocol was approved by the Research Ethics Commit-
tee of the College of Animal Science, Fujian Agriculture 
and Forestry University, under Permit Number PZCAS-
FAFU2014002. All surgeries were performed under ether 
anaesthesia to minimize suffering and discomfort as 
much as possible. All animals received humane care in 
compliance with the university’s guidelines.
Virus, cell lines and peptides
Influenza virus strain A/Puerto Rico/8/1934 (H1N1) 
(hereafter referred to as PR8) was propagated in SPF 
chicken embryos as previously described [22]. Viruses 
were then harvested and preserved at −80  °C prior 
to use. Virus titres were determined using a standard 
plaque-forming unit (PFU) assay in MDCK cells. The 
titre of the virus stock obtained was 6.5 × 106 PFU/mL.
The 293T, A549 and MDCK cells used in the present 
study were purchased from American Type Culture Col-
lection. Cells were cultured at 37 °C with 5%  CO2 in Dul-
becco’s modified Eagle’s medium (DMEM) supplemented 
with 10% (v/v) foetal bovine serum (FBS) (Gibco, US), 
100 units of penicillin G, and 100 µg of streptomycin.
The NMB peptide and NMBR antagonist (NMBRA) 
were synthesized by manual solid-phase synthesis using 
standard Fmoc chemistry as previously described [23]. 
Synthetic NMB and NMBRA were dissolved in a 0.9% 
NaCl solution at doses of 1  nM and stored at −20  °C 
until use. The doses used here were selected based on 
a previous report [24] in addition to our own previous 
experiments.
shRNA‑based knockdown of NMBR and generation of cell 
lines
Short hairpin RNA (shRNA)-based knockdown cell lines 
were generated by transfection of A549 cells with lenti-
viral vectors expressing specific shRNAs in a previously 
described pSIH-H1-GFP vector [22]. Sequences for 
NMBR shRNA were designed using Invivogen’s online 
shRNA wizard. The shRNA targeting the NMBR gene 
(NMBR-shRNA), 5′-GGC AAT TGC ATG ATT GAC TCA-
3′, was designed. A control shRNA targeting the lucif-
erase gene (NC-shRNA), 5′-CTT ACG CTG AGT ACT 
TCG A-3′, was used. The oligonucleotide duplex for each 
target was cloned into the pSIH-H1-GFP shRNA expres-
sion vector. Plasmids expressing NC- and NMBR-shRNA 
were cloned. Stable A549 cells expressing NMBR-shRNA 
(sh-NMBR cells) or NC-shRNA (sh-Luciferase cells) were 
generated using viral spin infection as described previ-
ously [25]. The above vector expresses GFP under the 
control of the CMV promoter to allow monitoring of 
transfection efficiency. To measure the knockdown effi-
ciency, RT-PCR, quantitative RT-PCR (qRT-PCR) and 
Western blotting were performed.
Isolation of murine bone marrow‑derived macrophages 
(BMDMs)
Primary BMDMs were isolated as previously described 
[26]. Both femurs were dissected, and bone marrow 
was flushed out from the medullary cavities with Dul-
becco’s phosphate-buffered saline containing 1 × peni-
cillin/streptomycin. Cells were centrifuged for 10 min at 
1200 rpm at room temperature and then resuspended in 
complete medium (DMEM supplemented with 10% FBS 
(v/v), 1% penicillin/streptomycin, and 50 ng/mL M-CSF 
(recombinant murine M-CSF, RP-8615, Invitrogen Inc., 
USA)). The cells were cultured at 37  °C under 5%  CO2 
for 5 days with complete medium that was changed twice 
weekly. Approximately 5 × 106 BMDMs were obtained 
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from each mouse. The viability of BMDMs was > 95%, as 
confirmed by trypan blue exclusion staining.
Virus infection and treatment in vitro
In vitro infection of cells with the PR8 virus was per-
formed under biosafety level 2 (BSL-2) laboratory con-
ditions.  293T, A549, sh-NMBR, sh-Luciferase and 
BMDM cells were seeded in 6-well plates at 37 °C in 5% 
 CO2. When the cells grew to a density of approximately 
80–90% confluence, the cells were infected with PR8 at 
the indicated multiplicity of infection (MOI) with gen-
tle agitation every 15 min. After adsorption at 37  °C for 
1 h, the cells were washed with phosphate-buffered saline 
(PBS) and cultured in DMEM containing 2 μg/mL trypsin 
(Sigma-Aldrich). 293T and A549 cells were harvested 
at 0, 3, 6, 9, and 12 h post-infection (hpi) for NMB and 
NMBR expression analysis by RT-PCR and qRT-PCR. 
The sh-NMBR cells and sh-Luciferase cells were har-
vested at either 0, 6, or 12 hpi for gene expression analysis 
by RT-PCR and qRT-PCR and protein expression by WB. 
Supernatants of sh-NMBR cells and sh-Luciferase cells 
were harvested at 12, 24, 36, 48 and 64 hpi for virus titra-
tion. The viral titres were determined by plaque assay.
One hour after infection with PR8, the BMDMs and 
A549 cells were incubated with either 1  nM NMB or 
NMBR antagonist (NMBRA) and cultured at 37 °C in 5% 
 CO2. Meanwhile, the mock-treated cells were incubated 
with DMEM without NMB or NMBRA. Cells were har-
vested at 16 hpi for gene expression analysis by RT-PCR 
and qRT-PCR.
Infection of mice and treatments
Six groups of mice were set up: group 1 (PR8-Mock), 
group 2 (PR8-NMB +), group 3 (PR8-NMBRA+), group 
4 (PR8 + Mock), group 5 (PR8 + NMB +), and group 6 
(PR8 + NMBRA+). Each group contained twenty-five 
mice, with each mouse having a mass of approximately 
20–22  g. For this experimental setting, the animals in 
groups 1, 2, and 3 were mock-treated with 100 μL SPF 
chick embryo allantoic fluid, and the animals in groups 
4, 5, and 6 were anaesthetized and inoculated intranasally 
with 6.5 × 104 PFU of PR8 virus. On the day after infec-
tion, the animals in groups 1 and 4 were mock-treated 
with 100 μL 0.9% NaCl solution. Simultaneously, the ani-
mals in groups 2 and 5 were injected with 1 nM NMB in 
a volume of 100 μL, and the animals in groups 3 and 6 
received 100 μL 1 nM NMBRA. All mice were monitored 
daily for signs of flaccid paralysis, and any deaths were 
recorded. Ten mice from each group were euthanized on 
3 dpi, from which lung samples were collected and imme-
diately flash-frozen in liquid nitrogen and then stored at 
−80 °C until future RNA extraction. All other animals in 
each group were monitored daily for up to 10 days.
RT‑PCR and qRT‑PCR
Total RNA was extracted from PR8-infected and control 
cells at the indicated time points. In addition, RNA was 
extracted from mouse lung tissues at 3 dpi using Trizol 
(TIANGEN Biotech, China) according to the manufac-
turer’s instructions. Equal amounts of RNA (2  µg) were 
reverse transcribed into cDNA utilizing M-MLV Reverse 
Transcriptase (Promega, USA). The cDNA was analysed 
by qRT-PCR using the TransStart Green qPCR SuperMix 
(TransGen Biotech, China) and RT-PCR using rTaq DNA 
polymerase (Takara Bio, Japan). Human β-actin and glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH) were 
used as references for internal standardization. Ampli-
cons from the PCRs were separated on a 1.5% agarose 
gel, which was stained with nucleic acid stain I (Roche 
Diagnostics, Mannheim, Germany), photographed, and 
analysed using the Gene Tools Analysis Software (Syn-
gene, Cambridge, UK). The qRT-PCR data are presented 
as normalized ratios, which were calculated using the 
ΔΔCT method with the LightCycler system and software 
(Roche, Switzerland). All primers used for RT-PCR and 
qRT-PCR are presented in Tables 1 and 2.
Western blotting
Lung tissue lysates from the mice were prepared from 
tissues collected at 3 dpi. Lysates of sh-NMBR cells, sh-
Luciferase cells, PR8-infected sh-NMBR cells, and non-
infected controls were prepared from samples harvested 
Table 1 Primers used for RT-PCR and qRT-PCR in mouse 
tissue 
The primers designed for the NP gene listed in this table could also be used in 
human tissues after virus infection.
Primer names GenBank accession no. Sequence (5′–3′)
NMB sense NM_001291280.1 CGG TCA CTT CAT GGG CAA G
NMB antisense GAG CTT TCT TTC GCA GGA 
GGA 
NMBR sense NM_008703.3 CAT GCG GAA TGT CCC TAA 
CATC 
NMBR antisense CCA AGC TAC CAA TGC GTG 
CTAC 
β‑actin sense NM_007393.5 AAT GGG TCA GAA GGA 
CTC CT
β‑actin antisense ACG GTT GGC CTT AGG GTT 
CAG 
IL‑6 sense NM_001314054.1 TTG CCT TCT TGG GAC TGA TG
IL‑6 antisense TCT GGC TTT GTC TTT CTT GT
IFN‑α sense NM_206871.2 TCC TGC CTG AAG GAC AGG 
AAGG 
IFN‑α antisense AGG GCT CTC CAG ACT TCT 
GCT CTG 
NP sense CY034135.1 TCA AAC GTG GGA TCA ATG 
NP antisense GTG CAG ACC GTG CTA AAA 
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at 0, 6, and 12 hpi. All lysates were resolved by SDS-
PAGE in 10% polyacrylamide gels. Bands were detected 
using rabbit anti-H1N1-NP (generated in our laboratory) 
as previously described [27] and anti-hNMBR (ab134141, 
Abcam, USA). β-Actin was detected using a rabbit anti-
actin polyclonal antibody (R019, TransGen Biotech, 
China). The secondary antibodies for detection were goat 
anti-mouse (125229, Jackson ImmunoResearch Labo-
ratories, USA) and goat anti-rabbit antibodies (131879, 
Jackson ImmunoResearch Laboratories). The blots were 
developed using the FluorChem M Imaging System (Pro-
teinSimple, USA).
Plaque assay
The supernatant was diluted with medium and added 
to MDCK cell monolayers in 6-well plates. After 1 h of 
incubation in 5%  CO2 at 37  °C, the supernatant was 
removed, and the covering medium containing 1.5% low-
melting-point agarose (Promega, Madison, WI, USA) 
was then overlaid on the cells. After coagulation of aga-
rose, the maintenance medium was added, and the plates 
were further incubated for 3  days for plaque formation. 
Next, the cells were fixed with 10% formalin overnight 
and stained with crystal violet (1% W/V) for 30 min. The 
number of plaques was counted.
Statistical analysis
Survival curves were analysed using the log-rank 
test (GraphPad Prism5). Other data are presented as 
mean ± SEM. Differences were considered significant 
when P ≤ 0.05. Statistical analysis was completed by one-
way ANOVA using SPSS 16.0 (Chicago, IL, USA).
Results
Expression of NMB and NMBR is upregulated in 293T 
and A549 cells following PR8 infection
To determine the role of NMB and its receptor, NMBR, in 
the host antiviral response to IAV infection, the expres-
sion of NMB and NMBR was analysed in 293T and A549 
cells at 0, 3, 6, 9, and 12 hpi. The expression levels of both 
NMB and NMBR were very low in the mock-treated con-
trols (0 hpi). The expression level of NMB was slightly 
increased, whereas the expression of NMBR was clearly 
increased, in 293T cells in response to virus infection 
(Figure 1A). Consistent with that, the results from qRT-
PCR showed that the expression of NMB mRNA was 
significantly increased at 12 hpi (Figure 1B), and expres-
sion of NMBR mRNA was significantly increased at 6, 
9, and 12 hpi (Figure 1C). Similar profiles of both NMB 
and NMBR expression following infection with PR8 were 
also observed in A549 cells (Figures 1D–F). To determine 
whether trypsin addition had any side effects during PR8 
infection, the expression of IL-6 and protease-activated 
receptors 2 (PAR2) was investigated. It was observed that 
trypsin had no significant effect on IL-6 mRNA or PAR2 
protein level in response to PR8 infection (Additional 
file 1). These results indicated that PR8 infection can sig-
nificantly induce the expression of NMBR in host cells.
PR8 infection increases NMB and NMBR expression in vivo
To better understand the potential roles of NMB and 
NMBR in the host innate immune response to IAV 
infection, mice were infected with PR8, and lung tis-
sues of PR8-infected and non-infected control animals 
were collected at 3 dpi. The tissue-specific expression of 
NMB and NMBR mRNA was assessed by RT-PCR and 
qRT-PCR. Similarly to above, it was observed that the 
expression of NMB and NMBR increased in lung tissues 
following infection with PR8 (Figures 1G–I).
Cells deficient in NMBR are more susceptible to PR8 
infection
To test the hypothesis that NMB/NMBR plays a role in 
the host defences against IAV infection, A549 cells defi-
cient in NMBR were generated. The transfection effi-
ciency of the shRNA expression plasmid vector used in 
this study, as determined by the proportion of GFP-posi-
tive cells, is presented in Figure 2A. To verify the efficacy 
of the shRNA-mediated knockdown of NMBR in A549 
cells, the expression of NMBR mRNA in sh-Luciferase 
controls and sh-NMBR cells was examined by RT-PCR 
and qRT-PCR (Figures  2B, C), and protein expression 
Table 2 Primers used for RT-PCR and qRT-PCR in human 
cells 
Primer names GenBank accession no. Sequence (5′–3′)
NMB sense NM_021077.4 TAA AGA AGG CTC TGG 
GCG TG
NMB antisense GGT GAC CCA GCC AGA 
AAT CA
NMBR sense NM_002511.3 ACC TAA ATC GTG GGC 
GTT CA
NMBR antisense GGC AGG AAA TCC CTT 
TCC CA
GAPDH sense NM_002046.7 TGG GTG TGA ACC ATG 
AGA AGT 
GAPDH antisense AAG GCC ATG CCA GTG 
AGC TT
IL‑6 sense NM_000600.5 ACA AAT TCG GTA CAT CCT 
CGAC 
IL‑6 antisense TGG CTT GTT CCT CAC 
TAC TCT 
IFN‑α sense J00210.1 TGA TCT GCC TCA AAC 
CCA CA
IFN‑α antisense ATC TGC TGG ATC ATC TCA 
TGG 
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was examined by Western blotting (Figure 2D). The data 
demonstrated that shRNA targeting of NMBR efficiently 
silenced the expression of NMBR in the A549 cell line.
Next, the sh-NMBR and sh-Luciferase control cells 
were infected with PR8 and harvested at 0, 6, and 12 
hpi. NP expression was slightly enhanced in the NMBR-
deficient cells compared to the mock-treated cells (Fig-
ure 3A). To confirm the reliability of these data, qRT-PCR 
was performed to measure the expression of NP, and 
a more significant result was obtained from this assay 
(Figure  3B). Similarly, the Western blot results showed 
that the expression of NP was substantially upregulated 
in the NMBR-deficient cells (Figure  3C). In addition, 
virus replication in NMBR-deficient cells was higher than 
that of control cells in the plaque assay (Figure  3D). To 
demonstrate the potential impact of NMBR signalling on 
the host innate immune system, the expression of IFN-α 
and IL-6 in the context of PR8 infection was assessed in 
sh-NMBR cells by RT-PCR. The data indicated a decrease 
in IFN-α expression, whereas the expression of IL-6 was 
Figure 1 PR8 induction of NMB and NMBR expression. 293T and A549 cells were infected with PR8 (MOI = 1) and harvested at 0, 6, and 12 hpi, 
and lung tissues were harvested at 3 dpi, to measure the expression of NMB and NMBR by RT‑PCR and qRT‑PCR. A–C Expression of NMB and NMBR 
in 293T cells. D–F Expression of NMB and NMBR in A549 cells. G–I NMB and NMBR expression in mouse lungs. GAPDH, glyceraldehyde‑3‑phosphate 
dehydrogenase; NP, virus nucleoprotein; β‑actin or GAPDH were used as reference housekeeping genes for internal standardization. *P < 0.05, 
**P < 0.01.
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upregulated in these cells (Figure  4A). The observed 
gene expression profile of IFN-α and IL-6 was further 
confirmed by qRT-PCR (Figures 4B, C). Taken together, 
these data suggest that NMBR is an important compo-
nent in the host innate defence against IAV infection.
NMB/NMBR inhibits PR8 infection in vitro
To determine the effect of NMB on PR8 infection, the 
effects of NMB and NMBRA on the expression of viral 
NP, IFN-α and IL-6 were examined in A549 cells and 
BMDMs. NP expression was significantly reduced fol-
lowing NMB treatment in A549 cells (Figures  5A, 
B). Furthermore, treatment with NMB resulted in an 
upregulation of IFN-α (Figures 5A, C) and downregula-
tion of IL-6 expression (Figures  5A, D) in PR8-infected 
A549 cells. Indeed, viral NP expression was increased 
in A549 cells treated with 1  nM NMBRA (Figures  6A, 
B). The expression of IFN-α in A549 cells was markedly 
downregulated (Figures 6A, C), and IL-6 was upregulated 
(Figures  6A, D) by NMBRA treatment after PR8 infec-
tion. In BMDMs, similar expression levels of NP, IFN-α 
and IL-6 mRNA induced by NMB treatment or NMBRA 
treatment were observed in BMDMs after PR8 infec-
tion (Additional files 2, 3). Thus, the expression profile of 
these genes in the presence of NMBRA was in contrast 
to that of NMB-treated cells. Meanwhile, the expression 
of IL-6 mRNA and PAR2 in BMDMs and the expression 
of NMBR in A549 cells and BMDMs were not affected 
Figure 2 Stable transfection of A549 cells with NMBR shRNA. A 
Bright‑field microscopy of cells transfected with shRNA‑Luciferase (1, 
mock cells; 3, sh‑NMBR cells); GFP‑expressing cells were successfully 
transfected with shRNA‑Luciferase (2, mock cells; 4, sh‑NMBR cells). 
The expression of NMBR was assessed by RT‑PCR (B), qRT‑PCR (C) and 
WB (D). β‑Actin or GAPDH was used for internal standardization. All 
images were captured at ×200 magnification, scale bars = 200 μm, 
**P < 0.05.
Figure 3 Relative susceptibility of NMBR‑deficient cells to PR8 
infection. The sh‑NMBR cells and sh‑Luciferase cells were infected 
with PR8 (MOI = 1) and collected at 0, 6, and 12 hpi. The expression 
of NP was assessed by RT‑PCR (A), qRT‑PCR (B) and WB (C). Culture 
supernatants were collected to test the titres by plaque assay at 
12, 24, 36, 48 and 64 hpi (D). GAPDH was used as the reference 
housekeeping gene for internal standardization. **P < 0.01.
Figure 4 Cytokine expression in cells lacking NMBR after PR8 
infection. The cells were infected with PR8 (MOI = 1) and harvested 
to assay the expression of IFN‑α and IL‑6 at 0, 6, and 12 hpi. A RT‑PCR 
revealed a significant decrease in IFN‑α expression and a significant 
increase in IL‑6 expression in sh‑NMBR cells compared to mock cells 
(sh‑Luciferase cells); qRT‑PCR confirmed the expression profile of B 
IFN‑α and C IL‑6. **P < 0.01, *P < 0.05.
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by trypsin during PR8 infection (Additional file  4), sug-
gesting that trypsin is not involved in the effects of NMB 
and NMBRA treatments in PR8-infected cells. Together, 
the results reveal that NMB/NMBR induced a substan-
tial increase in IFN-α and a significant decrease in IL-6 
expression in response to PR8 infection.
NMB/NMBR exhibits anti‑influenza virus activity in vivo
To investigate the anti-IAV activity of NMB/NMBR 
in  vivo, mice were infected with PR8 and then injected 
with NMB, NMBRA, or mock control. As expected, PR8 
challenge resulted in clinical signs consistent with PR8 
infection in mice at 3 dpi (Figure 7A). However, the clini-
cal signs were markedly less severe in animals treated 
with NMB and were exacerbated in the NMBRA-treated 
group (Figure  7A). To further determine the effects of 
NMB or NMBRA in vivo, mortality rates were compared 
between the groups over the 10-day period following PR8 
challenge. As can be seen in Figure 7B, the control mice 
began to die by 4 dpi, and all mice succumbed by 5 dpi. 
However, mortality was reduced to 50% in the NMB-
treated mice. Similar to the infection control group, all 
mice died in the NMBRA treatment group within 4.5 days 
after infection. Notably, all mice in the mock group sur-
vived the duration of the experiment. As presented in 
Figure 7C, the weight gain of all mice increased steadily 
in the three PR8-negative groups. Mice infected with PR8 
exhibited a precipitous weight loss after 1  day, decreas-
ing to less than 75% after 5 days. Mice infected with PR8 
and treated with NMBRA lost weight faster than the PR8 
infection-alone group. Interestingly, mice treated with 
NMB after virus challenge exhibited a steady weight gain 
after 7 days of continual weight loss. Consistent with the 
data from the above in  vitro experiments, the lung tis-
sues were sampled for analysis of viral NP expression, 
and NMB treatment resulted in a downregulation of NP 
expression following PR8 infection (Figures 8A, B). Anal-
ysis of protein expression by Western blotting confirmed 
that NMB treatment effectively inhibited the expression 
of NP protein in the lungs of mice infected with PR8 (Fig-
ure  8C). Moreover, the expression profiles of viral NP 
mRNA and protein after treatment with NMBRA were 
also assessed by RT-PCR, qRT-PCR and Western blot-
ting. The expression of NP in the NMBRA-treated ani-
mals was opposite to that observed in the NMB-treated 
group (Figures 8D–F). Taken together, these data suggest 
Figure 5 Effect of NMB treatment on the expression of viral NP 
and cytokines in A549 cells. The A549 cells were mock‑treated or 
treated with NMB after infection with PR8 (MOI = 1). NMB‑treated 
cells were harvested at 16 hpi. A The mRNA levels of NP, IFN‑α, and 
IL‑6 were measured by RT‑PCR. qRT‑PCR measurement of NP (B), 
IFN‑α (C) and IL‑6 (D) mRNA expression. GAPDH was used as the 
reference housekeeping gene for internal standardization. **P < 0.01, 
*P < 0.05.
Figure 6 Effect of NMBRA treatment on the expression of viral 
NP and cytokines in A549 cells. The A549 cells were mock‑treated 
or treated with NMBRA after infection with PR8 (MOI = 1). 
NMBRA‑treated cells were harvested at 16 hpi. A The mRNA levels of 
NP, IFN‑α, and IL‑6 were measured by RT‑PCR. The expression of NP 
(B), IFN‑α (C), and IL‑6 (D) were measured by qRT‑PCR. GAPDH was 
used as the reference housekeeping gene for internal standardization. 
**P < 0.01, *P < 0.05.
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that the expression of NMB could reduce the susceptibil-
ity of mice to PR8 infection.
Next, RT-PCR and qRT-PCR were used to determine 
the expression of IFN-α and IL-6 in mice infected with 
PR8 alone or in the context of NMB or NMBRA treat-
ment. The combination of PR8 infection and NMB treat-
ment induced a significant increase in IFN-α expression 
(Figures  9A, B) and decreased IL-6 expression (Fig-
ures 9A, C). Specifically, RT-PCR and qRT-PCR analysis 
indicated that NMBRA treatment induced a substan-
tial decrease in IFN-α and a significant increase in IL-6 
expression (Figures 9D–F). Thus, the effects of NMBRA 
were in contrast to those of NMB in PR8-infected mice, 
as expected.
Discussion
A key member of the neuroendocrine system, NMB con-
trols various exocrine and endocrine functions through 
signalling cascades upon binding to its receptor, NMBR 
[20, 28]. Although research into the antiviral activity of 
this protein in mammals has not been thoroughly exam-
ined, it has been well characterized in the context of 
immune regulation [19]. However, the expression profiles 
of NMB and NMBR during IAV infection and the activ-
ity of NMB/NMBR in hosts during virus infection remain 
unclear. The present study reports, for the first time, the 
expression and activity of NMB/NMBR in response to 
PR8 infection.
Interestingly, the upregulation of NMB and NMBR was 
detected after the virus challenge. A significant increase 
in NMBR expression was observed in the infected host. 
These data indicate that NMBR may be involved in the 
pathological or host defence processes of PR8/IAV infec-
tion. It is well known that many viruses are capable of 
modulating the expression of inflammatory cytokines 
(e.g., IL-6), thus allowing the virus to establish a suc-
cessful infection [29–31]. Although it appears from the 
data presented here that induction of NMBR in response 
to IAV/PR8 infection is indeed part of the host innate 
response and is detrimental to the virus, further studies 
are necessary to confirm these findings.
Strikingly, the data presented here demonstrated that 
the disruption of NMBR signalling resulted in increased 
PR8 replication in  vitro. This conclusion was supported 
by the fact that the depletion of NMBR increased the 
susceptibility of host cells to PR8 infection. Although the 
Figure 7 Effects of NMB and NMBRA treatment on virus replication in vivo. A Representative photographs of mock‑treated mice infected with 
PR8, PR8‑infected mice treated with 1 nM NMB, and PR8‑infected mice treated with 1 nM NMBRA; B survival rates of mice in 6 treatment groups; 
C body weights of the 6 groups of mice. The mice were monitored for up to 10 days, and survival curves were compared using a log‑rank test 
(GraphPad Prism 5). **P < 0.01, *P < 0.05.
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roles of IFN-α are beneficial for the host following viral 
infection, the excessive production of IL-6 stimulated 
by IAV infection can result in pathogenic effects in the 
host organs, increasing the risk of severe disease and 
death [32, 33]. Here, it was observed that the increased 
expression of IL-6 and decreased expression of IFN-α 
were induced in NMBR-deficient cells in response to 
PR8 infection. It is very likely that the high expression 
level of IL-6 and reduced IFN-α expression in cells lack-
ing NMBR are contributing factors in the pathogenesis of 
PR8. Our results indicate that endogenous NMBR is an 
important part of the host defence against PR8 infection. 
Therefore, we hypothesized that the NMBR ligand, NMB, 
is a potential therapeutic agent for the treatment of PR8 
infection.
To test the above hypothesis, the anti-influenza virus 
activity of NMB was examined both in vitro and in vivo. 
The data collected from all of the experiments that were 
conducted corroborated the hypothesis that NMB can 
inhibit IAV replication. As expected, NMB treatment 
reduced the clinical signs associated with PR8 infection. 
These results suggest that NMB is an important fac-
tor in combating PR8 infection. However, the specific 
antiviral mechanisms of NMB remain unclear. In the 
present study, NMB suppressed the expression of IL-6 
in PR8-infected cells and mice. Since IL-6 plays a vital 
role in the pathogenesis of H1N1 [34], this may, at least 
in part, explain the anti-PR8 effect of NMB. It has been 
established that there is cross-talk between IL-6 signal-
ling and IFN-α/β signalling [35–38]. The rapid induction 
of type I IFN is a critical step in the establishment of the 
innate antiviral response [17, 18]. Consistent with this 
concept, NMB treatment reversed the expression profiles 
of IFN-α and IL-6 induced by PR8 infection both in vitro 
and in  vivo. Furthermore, when synthetic NMBRA was 
injected into mice after PR8 infection, the cytokine 
expression profiles reversed relative to those under NMB 
treatment, thus corroborating the observed antiviral 
activity of NMB. Therefore, it is likely that NMB plays an 
anti-inflammatory role via the regulation of the host type 
I IFN signalling pathway. Of course, the signalling path-
way in which NMB participates requires further research.
Figure 8 Effects of NMB and NMBRA treatments on the expression of virus NP in mice. Lung tissues from treated mice were sampled at 3 
dpi. The profiles of NP expression were assayed by RT‑PCR, qRT‑PCR or Western blotting. Decreased virus NP expression after NMB treatment was 
observed (A–C); increased virus NP expression induced by NMBRA treatment was confirmed (D–F). β‑Actin was used for internal standardization. 
*P < 0.05.
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The present data represent the first demonstration of 
the in vitro and in vivo efficacy of NMB/NMBR against 
PR8 infection. Cells deficient in NMBR expression 
exhibited increased susceptibility to the influenza A 
virus. Furthermore, the NMB/NMBR system appeared 
to increase IFN-α expression and decrease IL-6 expres-
sion after PR8 infection, which may serve to establish 
an antiviral state in the host. The effects observed fol-
lowing PR8 infection and NMBRA treatment further 
suggest an important role of NMB in antiviral immu-
nity. However, the potential activity of NMB/NMBR 
against other viruses requires further research. These 
results provide a critical basis for the future therapeutic 
application of NMB/NMBR against IAV infection.
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Additional file 1. Effect of trypsin on the expression of IL‑6 and PAR2 
in cells. The 293T and A549 cells were infected with PR8 (MOI = 1) in 
the presence or absence of trypsin. The 293T cells at 0, 3 and 12 hpi and 
A549 cells at 0, 3, 12, and 16 hpi were collected to test the expression 
of IL‑6 mRNA in 293T and A549 cells by RT‑PCR and qRT‑PCR and the 
expression of PAR2 and NMBR in A549 cells by Western blotting. (A, B) IL‑6 
mRNA expression in 293T cells. (C) PAR2 expression in 293T cells. (D, E) IL‑6 
mRNA expression in A549 cells. (F) PAR2 expression in A549 cells. GAPDH 
and β‑actin were used as the reference housekeeping genes for internal 
standardization.
Additional file 2. Effect of NMB treatment on the expression of viral 
NP and cytokines in BMDMs. The BMDMs were mock‑treated or treated 
with NMB after infection with PR8 (MOI = 1). NMB‑treated cells were 
harvested at 16 hpi. The mRNA levels of NP, IFN‑α, and IL‑6 were measured 
by RT‑PCR (A). qRT‑PCR measurement of NP (B), IFN‑α (C) and IL‑6 mRNA 
expression (D). β‑Actin was used as the reference housekeeping gene for 
internal standardization. ** P < 0.01.
Additional file 3. Effect of NMBRA treatment on the expression of 
viral NP and cytokines in BMDMs. The BMDMs were mock‑treated or 
treated with NMBRA after infection with PR8 (MOI = 1). NMBRA‑treated 
cells were harvested at 16 hpi. mRNA levels of NP, IFN‑α, and IL‑6 meas‑
ured by RT‑PCR (A). The expression of NP (B), IFN‑α (C), and IL‑6 (D) was 
measured by qRT‑PCR. β‑Actin was used as the reference housekeeping 
gene for internal standardization. **P < 0.01.
Figure 9 Effects of NMB and NMBRA treatment on the expression of cytokines in mice. Lung tissues from treated mice were sampled at 3 
dpi. The expression patterns of IFN‑α and IL‑6 in lung tissues were assessed using RT‑PCR and qRT‑PCR. NMB treatment induced the upregulation of 
IFN‑α (A, B) and downregulation of IL‑6 (A, C); NMBRA treatment induced the downregulation of IFN‑α (D, E) and upregulation of IL‑6 (D, F). β‑Actin 
was used as the reference housekeeping gene for internal standardization *P < 0.05; **P < 0.01.
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Additional file 4. Effect of trypsin on the expression of IL‑6, PAR2 
and NMBR in vitro. The BMDMs and A549 cells were infected with PR8 
(MOI = 1) in the presence or absence of trypsin. The BMDMs and A549 
cells were collected at the indicated times to test the expression of IL‑6 
mRNA by RT‑PCR and qRT‑PCR and the expression of PAR2 and NMBR by 
Western blotting. (A, B) IL‑6 mRNA expression in BMDMs. (C) PAR2 and 
NMBR expression in BMDMs. (D) NMBR expression in A549 cells. β‑Actin 
was used as the reference housekeeping gene for internal standardization.
Abbreviations
BMDMs: bone marrow‑derived macrophages; dpi: days post‑infection; hpi: 
hours post‑infection; IAV: influenza A virus; IFN‑α/β: type I interferon; MOI: 
multiplicity of infection; NMB: neuromedin B; NMBR: neuromedin B recep‑
tor; NMBRA: NMBR antagonist; NP: nucleoprotein; PAR2: protease‑activated 
receptors 2; PFU: plaque‑forming unit; qRT‑PCR: quantitative real‑time RT‑PCR; 
shRNA: short hairpin RNA; SPF: specific pathogen‑free.
Acknowledgements
All authors would like to thank Dr. Song Wang for his contribution to this work 
and to thank Mogo Edit for scientific editing assistance.
Authors’ contributions
JLC and GY conceived and designed the study, and GY wrote the paper. GY, 
HH, MT and ZC performed the experiments. GY and HH analysed and inter‑
preted the data. CH and BQ provided critique and advice on the manuscript. 
JLC supervised the paper. All authors read and approved the final manuscript.
Funding
This work was supported by the National Nature Science Foundation of China 
(U1805231, 31602046 and 31302050), the FAFU Program for Promising Aca‑
demic Youngsters (2014), and the National Key Research and Development 
Program of China (2016YFD0500205).
Competing interests
The authors declare that they have no competing interests.
Received: 13 May 2019   Accepted: 29 August 2019
References
 1. Moise NS (1985) Viral respiratory diseases. Vet Clin North Am Small Anim 
Pract 15:919–928
 2. De Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang 
DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha DQ, Guan Y, Peiris 
JS, Chinh NT, Hien TT, Farrar J (2006) Fatal outcome of human influenza A 
(H5N1) is associated with high viral load and hypercytokinemia. Nat Med 
12:1203–1207
 3. Zhou J, Wang D, Gao R, Zhao B, Song J, Qi X, Zhang Y, Shi Y, Yang L, Zhu 
W, Bai T, Qin K, Lan Y, Zou S, Guo J, Dong J, Dong L, Zhang Y, Wei H, Li X, 
Lu J, Liu L, Zhao X, Li X, Huang W, Wen L, Bo H, Xin L, Chen Y, Xu C et al 
(2013) Biological features of novel avian influenza A (H7N9) virus. Nature 
499:500–503
 4. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, Lochindarat 
S, Nguyen TK, Nguyen TH, Tran TH, Nicoll A, Touch S, Yuen KY, Writing 
Committee of the World Health Organization (WHO), Consultation on 
Human Influenza A/H5 (2005) Avian influenza A (H5N1) infection in 
humans. N Engl J Med 353:1374–1385
 5. Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, Yao H, Wo J, Fang Q, Cui D, 
Li Y, Yao X, Zhang Y, Wu H, Zheng S, Diao H, Xia S, Zhang Y, Chan KH, Tsoi 
HW, Teng JL, Song W, Wang P, Lau SY, Zheng M, Chan JF, To KK, Chen H, Li 
L, Yuen KY (2013) Human infections with the emerging avian influenza A 
H7N9 virus from wet market poultry: clinical analysis and characterization 
of viral genome. Lancet 381:1916–1925
 6. De Clercq E (2006) Antiviral agents active against influenza A viruses. Nat 
Rev Drug Discov 5:1015–1025
 7. Lackenby A, Thompson CI, Democratis J (2008) The potential impact 
of neuraminidase inhibitor resistant influenza. Cur Opin Infect Dis. 
21:626–638
 8. Sheu TG, Deyde VM, Okomo‑Adhiambo M, Garten RJ, Xu X, Bright RA, 
Butler EN, Wallis TR, Klimov AI, Gubareva LV (2008) Surveillance for neu‑
raminidase inhibitor resistance among human influenza A and B viruses 
circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother 
52:3284–3292
 9. Bright RA, Medina MJ, Xu X, Perez‑Oronoz G, Wallis TR, Davis XM, Povinelli 
L, Cox NJ, Klimov AI (2005) Incidence of adamantane resistance among 
influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause 
for concern. Lancet 366:1175–1181
 10. Deyde VM, Xu X, Bright RA, Shaw M, Smith CB, Zhang Y, Shu Y, Gubareva 
LV, Cox NJ, Klimov AI (2007) Surveillance of resistance to adamantanes 
among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J 
Infect Dis 196:249–257
 11. Cheng PK, Leung TW, Ho EC, Leung PC, Ng AY, Lai MY, Lim WW (2009) 
Oseltamivir‑ and amantadine‑resistant influenza viruses A (H1N1). Emerg 
Infect Dis 15:966–968
 12. Dong G, Peng C, Luo J, Wang C, Han L, Wu B, Ji G, He H (2015) Adaman‑
tane‑resistant influenza a viruses in the world (1902‑2013): frequency and 
distribution of M2 gene mutations. PLoS One 10:e119115
 13. Jefferson T, Demicheli V, Di Pietrantonj C, Rivetti D (2005) Amantadine 
and rimantadine for influenza A in adults. Cochrane Database Syst Rev 
2:CD001169
 14. Hama R, Jones M, Okushima H, Kitao M, Noda N, Hayashi K, Sakaguchi K 
(2011) Oseltamivir and early deterioration leading to death: a propor‑
tional mortality study for 2009A/H1N1 influenza. Int J Risk Saf Med. 
23:201–215
 15. Moscona A (2009) Global transmission of oseltamivir‑resistant influenza. 
New Engl J Med 360:953–956
 16. Baillie KJ, Digard P (2013) Influenza—time to target the host? N Engl J 
Med 369:191–193
 17. Amadori M (2007) The role of IFN‑alpha as homeostatic agent in the 
inflammatory response: a balance between danger and response? J 
Interferon Cytokine Res 27:181–189
 18. Gough D, Messina N, Clarke CJ, Johnstone RW, Levy DE (2009) Constitu‑
tive type I interferon modulates homeostatic balance through tonic 
signaling. Immunity 31:166–174
 19. Gajjar S, Patel BM (2017) Neuromedin: an insight into its types, receptors 
and therapeutic opportunities. Pharmacol rep 69:438–447
 20. Ohki‑Hamazaki H (2000) Neuromedin B. Prog neurobiol 62:297–312
 21. Zhang WS, Fei KL, Wu MT, Wu XH, Liang QH (2012) Neuromedin B and 
its receptor influence the activity of myometrial primary cells in vitro 
through regulation of il6 expression via the Rela/p65 pathway in mice. 
Biol Reprod 86:154–157
 22. Wang S, Chi X, Wei H, Chen Y, Chen Z, Huang S, Chen JL (2014) Influenza 
a virus‑induced degradation of eukaryotic translation initiation factor 4b 
contributes to viral replication by suppressing ifitm3 protein expression. J 
Virol 88:8375–8385
 23. Li W, Gao YH, Chang M, Peng YL, Yao J, Han RW, Wang R (2009) Neuropep‑
tide S inhibits the acquisition and the expression of conditioned place 
preference to morphine in mice. Peptides 30:234–240
 24. Gemmill ME, Eskay RL, Hall NL, Douglass LW, Castonguay TW (2003) Lep‑
tin suppresses food intake and body weight in corticosterone‑replaced 
adrenalectomized rats. J Nutr 133:504–509
 25. Yang J, Wang J, Chen K, Guo G, Xi R, Rothman PB, Whitten D, Zhang L, 
Huang S, Chen JL (2013) eIF4B phosphorylation by Pim kinases plays 
a critical role in cellular transformation by Abl oncogenes. Cancer Res 
73:4898–4908
 26. Watanabe Y, Tsuchiya A, Seino S, Kawata Y, Kojima Y, Ikarashi S, Starkey 
Lewis PJ, Lu WY, Kikuta JC, Kawai H, Yamagiwa S, Forbes SJ, Ishii M, Terai 
S (2018) Mesenchymal stem cells and induced bone marrow‑derived 
macrophages synergistically improve liver fibrosis in mice. Stem Cells 
Transl Med 8:271–284
 27. Wang S, Zhang L, Zhang R, Chi X, Yang Z, Xie Y, Shu S, Liao Y, Chen J (2018) 
Identification of two residues within the NS1 of H7N9 influenza A virus 
that critically affect the protein stability and function. Vet Res 49:98
 28. Minamino N, Sudoh T, Kangawa K, Matsuo H (1985) Neuromedins: novel 
smooth‑muscle stimulating peptides identified in porcine spinal‑cord. 
Peptides 6:245–248
Page 12 of 12Yang et al. Vet Res           (2019) 50:80 
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
 29. Tudor D, Riffault S, Carrat C, Lefèvre F, Bernoin M, Charley B (2001) Type 
I IFN modulates the immune response induced by DNA vaccination to 
pseudorabies virus glycoprotein C. Virology 286:197–205
 30. Dénes A, Boldogkoi Z, Hornyák A, Palkovits M, Kovács KJ (2006) Attenu‑
ated pseudorabies virus‑evoked rapid innate immune response in the rat 
brain. J Neuroimmunol 180:88–103
 31. Miller LC, Zanella EL, Waters WR, Lager KM (2010) Cytokine protein 
expression levels in tracheobronchial lymph node homogenates of pigs 
infected with pseudorabies virus. Clin Vaccine Immunol 17:728–734
 32. La Gruta NL, Kedzierska K, Stambas J, Doherty PC (2007) A question of 
self‑preservation: immunopathology in influenza virus infection. Immu‑
nol Cell Biol 85:85–92
 33. Wei H, Wang S, Chen Q, Chen Y, Chi X, Zhang L, Huang S, Gao GF, Chen 
JL (2014) Suppression of interferon lambda signaling by socs‑1 results in 
their excessive production during influenza virus infection. PLoS Pathog 
10:e1003845
 34. Ramirez‑Garcia J, Gabriel JL, Alonso‑Ayuso M, Quemada M (2015) 
Quantitative characterization of five cover crop species. J Agric Sci 
153:1174–1185
 35. Stadnyk A, Gauldie J (1991) The acute phase protein response during 
parasitic infection. Immunol Today 12:A7–A12
 36. Taniguchi T, Takaoka A (2001) A weak signal for strong responses: inter‑
feron‑ alpha/beta revisited. Nat Rev Mol Cell Biol 2:378–386
 37. Mitani Y, Takaoka A, Kim SH, Kato Y, Yokochi T, Tanaka N, Taniguchi T (2010) 
Cross talk of the interferon‑alpha/beta signalling complex with gp130 for 
effective interleukin‑6 signaling. Genes Cells 6:631–640
 38. Chen Z, Luo G, Wang Q, Wang S, Chi X, Huang Y, Wei H, Wu B, Huang S, 
Chen JL (2015) Muscovy duck reovirus infection rapidly activates host 
innate immune signaling and induces an effective antiviral immune 
response involving critical interferons. Vet Microbiol 175:232–243
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub‑
lished maps and institutional affiliations.
